Stock screener

ACET

Conviction 73HealthcareScan · Thu, Jun 25, 2026
ACET$8.03-2.73%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
16
16
Vol MA14 77.64K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Adicet Bio, Inc.PHARMACEUTICAL PREPARATIONSwww.adicetbio.com
Price8.03
Change-2.73%
Gap+0.48%
Rel volume1.35×
Avg volume90.99K
Avg $ vol741.76K
SMA 208.01
SMA 508.05
SMA 2004.96
Price vs 50-0.30%
Price vs 200+61.73%
MA stackmixed
50/200 cross
Supertrenddown · 8.95
RSI (14)51
MACD hist0.03
MACD crossbull · 4d
Stoch %K / %D71 / 79
ADX (14)12
+DI / −DI25 / 21
RSI divergence
MACD divergenceBullish
ATR %+5.76%
ADR %5.91%
52w high9.31
52w low0.4650
From 52w high-13.80%
Above 52w low+1625.81%
New 52w highNo
SqueezeOff
Bollinger width25.79%
%B0.51
Donchian pos40.96%
Donchian high9.47
Donchian low7.02
AVWAP (52w high)8.14
vs AVWAP high-1.43%
AVWAP (52w low)4.01
vs AVWAP low+100.09%
OBV trendUp
Chaikin MF (20)-0.16
Today vs 20d1.35×
Avg vol (14d)77.64K
Avg vol (20d)90.99K
Avg $ vol (20d)741.76K
Market cap75.02M
RS 3m (vs SPY)+11.06%
RS 6m (vs SPY)+1563.32%
RS line new highNo
Trend template7/8
Technical rank72.8
1 week-0.93%
1 month-3.66%
3 months+17.84%
6 months+1531.76%
1 year+1126.69%
YTD-9.01%
P/E-0.64
P/B0.54
P/S
P/FCF-0.77
EPS-16.95
Div yield
ROE-83.39%
ROA-68.96%
Debt/Eq
Current7.66
EV/EBITDA-0.34
Gross margin
Net margin
Rev growth
EPS growth0.27%
Price target
Target upside
Analyst rating
Institutional
Ent. value38.77M
Revenue
Net income-20.24M
Gross profit
Free cash flow-96.98M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out9.35M
Employees102
ListedWed, Sep 16, 2020
Free float8.16M
Float %85.2%
Short interest517.92K
Days to cover4.2d
Short volume33.9%
Squeeze score39 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$2.42 · 2 est
Last EPS vs est
Last surprise
Setup gradeB
Conviction73 / 100
Pattern quality
Tech rank72.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance9.19
Support7.06
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ACET

All disclosures →
No recent disclosed trades by Congress in ACET. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACET · 6 buys · 4 sells

InsiderSideShares
RA CAPITAL MANAGEMENT, L.P.
10% owner · Common Stock · 2026-04-27
Dispose250K
Kolchinsky Peter
10% owner · Pre-Funded Warrant (Right to Buy) · 2026-04-27
Acquire250K
RA Capital Healthcare Fund LP
10% owner · Common Stock · 2026-04-27
Dispose250K
RA CAPITAL MANAGEMENT, L.P.
10% owner · Pre-Funded Warrant (Right to Buy) · 2026-04-27
Acquire250K
Shah Rajeev M.
10% owner · Common Stock · 2026-04-27
Dispose250K
RA Capital Healthcare Fund LP
10% owner · Pre-Funded Warrant (Right to Buy) · 2026-04-27
Acquire250K
Kolchinsky Peter
10% owner · Common Stock · 2026-04-27
Dispose250K
Shah Rajeev M.
10% owner · Pre-Funded Warrant (Right to Buy) · 2026-04-27
Acquire250K
Shah Rajeev M.
10% owner · Common Stock · 2026-02-20
Buy74.75K
RA CAPITAL MANAGEMENT, L.P.
10% owner · Common Stock · 2026-02-20
Buy74.75K

SEC filings

EDGAR filings in ACET · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.